Specialty code 183500000X · Manteca, CA
NPI
1164672069
Since 2008
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1777 W Yosemite Ave
Manteca, CA, 95337
Phone (209) 825-3616
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$289K
2,781 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Janet Trang prescribed most often to Medicare patients was Atorvastatin Calcium, with 374 prescriptions and refills. In total Janet Trang wrote 2,781 Medicare prescriptions that cost $289K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 374 | 1,242 | 165 | $4,649 |
| Metformin Hcl Er Metformin Hcl | 251 | 834 | 110 | $2,339 |
| Metformin Hcl Generic | 244 | 803 | 108 | $2,958 |
| Glipizide Generic | 205 | 681 | 97 | $2,570 |
| Humulin N Insulin Nph Human Isophane | 165 | 445 | 67 | $31K |
| Lisinopril Generic | 157 | 515 | 63 | $1,909 |
| Losartan Potassium Generic | 103 | 343 | 44 | $1,425 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 101 | 318 | 43 | $2,271 |
| Humulin R Insulin Regular, Human | 99 | 267 | 37 | $15K |
| Insulin Glargine-Yfgn Generic | 92 | 250 | 50 | $14K |
| Amlodipine Besylate Generic | 91 | 303 | 42 | $1,114 |
| Jardiance Empagliflozin | 90 | 285 | 39 | $49K |
| Victoza 2-Pak Liraglutide | 75 | 82 | 26 | $47K |
| Glipizide Er Glipizide | 64 | 212 | 34 | $1,618 |
| Simvastatin Generic | 61 | 203 | 28 | $716 |
Brand drugs: 682 claims; generic drugs: 1,861 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Janet Trang were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.